Press Releases from www.imarcgroup.com (1 total)
Biosimilar Entry to Inhibit Growth in the US and European Biopharmaceutical Mark …
"According to Imarc’s latest research report, “Global Biopharmaceutical Market Report (2010-2015)”, the combined sales of biopharmaceuticals in the United States and top five European Markets (Germany, France, Italy, Spain and United Kingdom) reached nearly US$ 68 Billion in 2009, growing at a CAGR of more than 11% during the last five years. One of the key reasons for the strong historical growth rates was the fact that these drugs…
